Broken redirects

Jump to navigation Jump to search

The following redirects link to non-existent pages:

Showing below up to 50 results in range #2,231 to #2,280.

View ( | ) (20 | 50 | 100 | 250 | 500)

  1. WELL-HART → Women’s Estrogen–Progestin Lipid-Lowering Hormone Atherosclerosis Regression Trial
  2. Wyeth-Ayerst Laboratories → Wyeth
  3. W chromosome → ZW sex-determination system
  4. Z chromosome → ZW sex-determination system
  5. ZEST-AMI → Zotarolimus-Eluting Stent Vs. Sirolimus-Eluting Stent Vs. Paclitaxel-Eluting Stent For Acute Myocardial Infarction Patients
  6. Brian Blank → User:Brian Blank
  7. Asiri Ediriwickrema → User:User:Asiri Ediriwickrema
  8. Myelodysplastic syndrome laboratory tests → wikidoc:Myelodysplastic syndrome laboratory findings
  9. Template:Coalworker's pneumoconiosis → Template:Coal worker's pneumoconiosis
  10. Template:Coalworker's pneumoconiosis (patient information) → Template:Coal worker's pneumoconiosis (patient information)
  11. Template:Commonscat1R → Template:Commonscat1
  12. WikiDoc News: Today In Medicine → Template:WikiDoc News: Today In Medicine
  13. Getting Started Video → Help:Getting started video
  14. Insert image → Help:Images
  15. Insert images → Help:Images
  16. How to insert images → Help:Images
  17. How to insert image → Help:Images
  18. Linking → Help:Links
  19. NOTOC → Help:Section
  20. Help → Help:Who what where why how
  21. Alkyl and aryl transferases → Category:EC 2.5
  22. Nitrogenous group transferases → Category:EC 2.6
  23. Carbon-carbon double bond isomerases → Category:EC 5.3.3
  24. Sulfur-sulfur bond isomerases → Category:EC 5.3.4
  25. Phosphotransferases (phosphomutases) → Category:EC 5.4.2
  26. Amide synthases → Category:EC 6.3.1
  27. Carbon-nitrogen ligases with glutamine as amide-n-donor → Category:EC 6.3.5
  28. AMI:Fixing the GAP-Quality Improvement Program for AMI Shown to be Effective → Special:Badtitle/NS100:AMI:Fixing the GAP-Quality Improvement Program for AMI Shown to be Effective
  29. A large study demonstrates no gender differences in short- and long-term outcomes following PCI → Special:Badtitle/NS100:A large study demonstrates no gender differences in short- and long-term outcomes following PCI
  30. A meta-analysis of over 180,000 patients suggests that drug eluting stents are safe for both on-label and off-label use → Special:Badtitle/NS100:A meta-analysis of over 180,000 patients suggests that drug eluting stents are safe for both on-label and off-label use
  31. Abciximab in addition to a high loading dose of clopidogrel does not improve outcomes in STEMI patients: Results from the BRAVE-3 Trial → Special:Badtitle/NS100:Abciximab in addition to a high loading dose of clopidogrel does not improve outcomes in STEMI patients: Results from the BRAVE-3 Trial
  32. Abnormal pressure gradient distal to the implanted bare metal stent is associated with the occurrence of in-stent restenosis → Special:Badtitle/NS100:Abnormal pressure gradient distal to the implanted bare metal stent is associated with the occurrence of in-stent restenosis
  33. Absorbable drug eluting stents are safe up to one year in single de novo coronary artery lesions → Special:Badtitle/NS100:Absorbable drug eluting stents are safe up to one year in single de novo coronary artery lesions
  34. Acoustic Cardiography: New Technique for Resynchronization Device Optimization May Provide Improved Outcomes → Special:Badtitle/NS100:Acoustic Cardiography: New Technique for Resynchronization Device Optimization May Provide Improved Outcomes
  35. Acute Myocardial Infarction with Hyperoxemic Therapy II (AMIHOT II) in ST Elevation MI with Rebuttal by Dr. Stone → Special:Badtitle/NS100:Acute Myocardial Infarction with Hyperoxemic Therapy II (AMIHOT II) in ST Elevation MI with Rebuttal by Dr. Stone
  36. Acute ischemic stroke: a decade of education and clinical investigation isn’t enough → Special:Badtitle/NS100:Acute ischemic stroke: a decade of education and clinical investigation isn’t enough
  37. Adjusting Clopidogrel loading dose according to platelet reactivity monitoring is associated with a decreased rate of stent thrombosis and no increase in bleeding → Special:Badtitle/NS100:Adjusting Clopidogrel loading dose according to platelet reactivity monitoring is associated with a decreased rate of stent thrombosis and no increase in bleeding
  38. Almost two years after implantation, Sirilimus-eluting coronary stents remain exposed to the circulation. August 11, 2007 → Special:Badtitle/NS100:Almost two years after implantation, Sirilimus-eluting coronary stents remain exposed to the circulation
  39. Angiomax Monotherapy Associated with Reduced Net Adverse Clinical Events, Major Bleeding and Cardiac‐Related Death Compared to Heparin Plus a Glycoprotein IIb/IIIa Inhibition in Primary PCI: Results of HORIZONS AMI → Special:Badtitle/NS100:Angiomax Monotherapy Associated with Reduced Net Adverse Clinical Events, Major Bleeding and Cardiac‐Related Death Compared to Heparin Plus a Glycoprotein IIb/IIIa Inhibition in Primary PCI: Results of HORIZONS AMI
  40. Antioxidants: WACS Study Demonstrates No Significant Benefit From Antioxidants For Preventing CVD → Special:Badtitle/NS100:Antioxidants: WACS Study Demonstrates No Significant Benefit From Antioxidants For Preventing CVD
  41. Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty 5 (ARMYDA-5) Presented Today at TCT 2007 → Special:Badtitle/NS100:Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty 5 (ARMYDA-5) Presented Today at TCT 2007
  42. Antiplatelets: Clopidogrel-to-Ticlopidine Crossover Study Demonstrates Drug Specific Resistance → Special:Badtitle/NS100:Antiplatelets: Clopidogrel-to-Ticlopidine Crossover Study Demonstrates Drug Specific Resistance
  43. Anxious individuals are at risk for heart attacks → Special:Badtitle/NS100:Anxious individuals are at risk for heart attacks
  44. Apixaban causes increased bleeding, but reduced ischemic events in patients with recent acute coronary syndrome: Results of the APPRAISE-1 Trial → Special:Badtitle/NS100:Apixaban causes increased bleeding, but reduced ischemic events in patients with recent acute coronary syndrome: Results of the APPRAISE-1 Trial
  45. Arginine metabolite found to predict mortality in patients with cardiogenic shock → Special:Badtitle/NS100:Arginine metabolite found to predict mortality in patients with cardiogenic shock
  46. Aspiration before Primary PCI Improves Outcomes: Results of EXPIRA and EXPORT → Special:Badtitle/NS100:Aspiration before Primary PCI Improves Outcomes: Results of EXPIRA and EXPORT
  47. Atherosclerosis: Study links atherosclerosis progression to traffic exposure → Special:Badtitle/NS100:Atherosclerosis: Study links atherosclerosis progression to traffic exposure
  48. Atrial tachyarrhythmia burden ≥5.5h in a day doubles the risk for thromboembolism in the TRENDS study → Special:Badtitle/NS100:Atrial tachyarrhythmia burden ≥5.5h in a day doubles the risk for thromboembolism in the TRENDS study
  49. Automated External Defibrillators offer no benefit in cardiac arrests that occur at home in the HAT trial → Special:Badtitle/NS100:Automated External Defibrillators offer no benefit in cardiac arrests that occur at home in the HAT trial
  50. BEAUTIFUL study fails to meet primary endpoint but demonstrates that heart rates can safely be reduced with Ivabradine → Special:Badtitle/NS100:BEAUTIFUL study fails to meet primary endpoint but demonstrates that heart rates can safely be reduced with Ivabradine

View ( | ) (20 | 50 | 100 | 250 | 500)

Retrieved from "https://www.wikidoc.org/index.php/Special:BrokenRedirects"